In these cases, MRD was positive (>0.01%) in 5 patients (38.4%) (4 B‐ALL and 1 T‐ALL), but also no difference was observed regarding p‐ERK and p‐Akt expression between those groups. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.